Botulinum toxin A in blepharospasm and hemifacial spasm.

M. Behari, K. K. Singh, S. Seshadri, K. Prasad, G. K. Ahuja

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


We report the first Indian experience of botulinum toxin A in the treatment of blepharospasm and hemifacial spasm. Sixteen patients, 7 with essential blepharospasm, 5 with Meige syndrome and 4 with hemifacial spasm received botulinum toxin A injection. One patient received 3 courses of injections, 2 received 2 courses and the rest received only one course. The effect was observed after a latent period of less than 48 hours in all patients and lasted for a mean of 16.65 weeks. More than 70% improvement occurred after 17/20 injections (85%). Poor response was more often seen when blepharospasm was associated with oromandibular dystonia (2/5 injections). Though the duration of response and subjective score of improvement was best in patients with hemifacial spasm, the numbers were very small for any statistical evaluation. The side effects were local, transient, mild and well tolerated. The commonest side effect was blepharoptosis.

Original languageEnglish (US)
Pages (from-to)205-208
Number of pages4
JournalThe Journal of the Association of Physicians of India
Issue number3
StatePublished - Mar 1994
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Botulinum toxin A in blepharospasm and hemifacial spasm.'. Together they form a unique fingerprint.

Cite this